Reflection Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$207K Buy
1,488
+102
+7% +$14.3K 0.13% 122
2025
Q4
$170K Buy
+1,386
New +$168K 0.12% 118

Other funds holding GILD

Reflection Asset Management's GILD Position: Q1 2026 in Review

Reflection Asset Management increased its Gilead Sciences (GILD) stake by 7.4% in Q1 2026, buying an estimated $14.3K and bringing the position to 1,488 shares worth $207K. The position accounts for 0.13% of the portfolio, ranked #122.

Reflection Asset Management first reported a position in GILD in Q4 2025 and has held it in 2 quarters since. 2,331 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Reflection Asset Management held 1,488 shares of Gilead Sciences worth $207K as of Q1 2026.
  • Reflection Asset Management bought 102 Gilead Sciences shares in Q1 2026, an estimated $14.3K.
  • Gilead Sciences made up 0.13% of Reflection Asset Management's portfolio in Q1 2026, its #122 holding.
  • Reflection Asset Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 2 quarters since.
  • 2,331 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Reflection Asset Management's 13F filing for Q1 2026, filed 26 Aug 2026.